Results 161 to 170 of about 2,707,119 (197)
AbstractObjectiveThe objective of the study is to report the performance of noninvasive prenatal testing (NIPT) in twin pregnancies after the treatment of assisted reproductive technology (ART).MethodIn two years period, 565 pregnant women with ART twin pregnancies were prospectively tested by NIPT for screening for trisomy 21 (T21), 18 (T18), and 13 ...
Yueqiu, Tan +16 more
openaire +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of Obstetrics and Gynaecology Research, 2023
AbstractObjectiveThis study examined how clients' selection and preference for noninvasive prenatal testing (NIPT) for aneuploidy changed with genetic counseling (GC) performed by certified geneticists at a primary hospital specializing in obstetrics, where other multiple prenatal genetic tests options were available.MethodsA total of 334 couples who ...
Katsuhiko Naruse +2 more
exaly +3 more sources
AbstractObjectiveThis study examined how clients' selection and preference for noninvasive prenatal testing (NIPT) for aneuploidy changed with genetic counseling (GC) performed by certified geneticists at a primary hospital specializing in obstetrics, where other multiple prenatal genetic tests options were available.MethodsA total of 334 couples who ...
Katsuhiko Naruse +2 more
exaly +3 more sources
Prenatal Diagnosis, 2018
AbstractObjectiveThe objectives of the study are to assess the accuracy of noninvasive prenatal testing (NIPT) for sex chromosome aneuploidies (SCAs) and to investigate patient decision‐making in clinical practice.Study designThis is a retrospective cohort study review of positive NIPT results for SCAs from January 2013 to September 2017.ResultsOf the ...
Jennifer Hoskovec +2 more
exaly +3 more sources
AbstractObjectiveThe objectives of the study are to assess the accuracy of noninvasive prenatal testing (NIPT) for sex chromosome aneuploidies (SCAs) and to investigate patient decision‐making in clinical practice.Study designThis is a retrospective cohort study review of positive NIPT results for SCAs from January 2013 to September 2017.ResultsOf the ...
Jennifer Hoskovec +2 more
exaly +3 more sources
Noninvasive prenatal testing and maternal obesity: A review
Noninvasive prenatal testing (NIPT) has become a popular screening test for the most common fetal aneuploidies. The performance of NIPT is affected by several factors including maternal obesity, which results in a greater rate of no-calls for obese ...
Louise Ambye +2 more
exaly +2 more sources
Detection of Maternal Malignancy after Abnormal Noninvasive Prenatal Testing (NIPT)
Blood, 2023Introduction: Noninvasive prenatal testing (NIPT) is routinely used to screen for fetal aneuploidies in chromosomes 13, 18 and 21. NIPT uses NGS based methods to detect fetal cfDNA in maternal circulation. In 2016, the American College of Obstetricians and Gynecologists recommended offering NIPT testing for all pregnant patients ...
Mwanasha Hamuza Merrill +7 more
openaire +1 more source
Noninvasive Prenatal Testing (NIPT): Current Status
2020The concept of circulating fetal cells in the mother was first discussed by a German pathologist, Georg Schmorl, who identified fetal trophoblasts in lungs of eclamptic women on autopsy in 1893 [1]. After this suggestion there was a hiatus of nearly 100 years before any development could be made in the field.
K. Aparna Sharma, Neerja Bhatla
openaire +1 more source
Clinical Obstetrics & Gynecology, 2023
Although nearly all noninvasive prenatal testing is currently based on analyzing circulating maternal cell-free DNA, the technical methods usedvary considerably. We review the different methods. Based on validation trials and clinical experience, there are mostly relatively small differences in screening performance for trisomies 21, 18, and 13 in ...
Peter, Benn, Howard, Cuckle
openaire +2 more sources
Although nearly all noninvasive prenatal testing is currently based on analyzing circulating maternal cell-free DNA, the technical methods usedvary considerably. We review the different methods. Based on validation trials and clinical experience, there are mostly relatively small differences in screening performance for trisomies 21, 18, and 13 in ...
Peter, Benn, Howard, Cuckle
openaire +2 more sources
Prenatal Diagnosis, 2019
AbstractObjectiveTo evaluate the reasons for nonreportable cell‐free DNA (cfDNA) results in noninvasive prenatal testing (NIPT), we retrospectively studied maternal characteristics and other details associated with the results.MethodsA multicenter retrospective cohort study in pregnant women undergoing NIPT by massively parallel sequencing (MPS) with ...
Nobuhiro Suzumori +55 more
openaire +2 more sources
AbstractObjectiveTo evaluate the reasons for nonreportable cell‐free DNA (cfDNA) results in noninvasive prenatal testing (NIPT), we retrospectively studied maternal characteristics and other details associated with the results.MethodsA multicenter retrospective cohort study in pregnant women undergoing NIPT by massively parallel sequencing (MPS) with ...
Nobuhiro Suzumori +55 more
openaire +2 more sources
Ultraschall in der Medizin - European Journal of Ultrasound, 2016
Purpose: Prenatal care has been significantly influenced by the introduction of noninvasive prenatal testing (NIPT) for aneuploidies in 2012. In Switzerland starting from July 2015 the national insurance companies cover NIPT as a second line screening for women who are at an intermediate or high risk after first trimester screening (FTS).
V Vinante +3 more
openaire +1 more source
Purpose: Prenatal care has been significantly influenced by the introduction of noninvasive prenatal testing (NIPT) for aneuploidies in 2012. In Switzerland starting from July 2015 the national insurance companies cover NIPT as a second line screening for women who are at an intermediate or high risk after first trimester screening (FTS).
V Vinante +3 more
openaire +1 more source
The Journal of Maternal-Fetal & Neonatal Medicine, 2017
In this first Asian study, the decision outcomes (decision conflict, decision regret, and anxiety) of 262 pregnant women offered noninvasive prenatal test (NIPT) for high-risk Down screening results were assessed. Decision conflict was experienced by 3.5% and level of decisional regret low (mean score 15.7, 95%CI 13.2-18.3).
Tsz-Kin, Lo +6 more
openaire +2 more sources
In this first Asian study, the decision outcomes (decision conflict, decision regret, and anxiety) of 262 pregnant women offered noninvasive prenatal test (NIPT) for high-risk Down screening results were assessed. Decision conflict was experienced by 3.5% and level of decisional regret low (mean score 15.7, 95%CI 13.2-18.3).
Tsz-Kin, Lo +6 more
openaire +2 more sources

